Echo Therapeutics, Inc. | 2013 | FY | 3


At December 31, 2012, the Company had the following outstanding warrants:

 

 

  Number of          
    Shares     Exercise   Date of
    Exercisable     Price   Expiration
Outstanding warrants accounted for in derivative warrant liability:              
Granted to financial investment advisor     7,500     $ 1.26   2/11/2013
Granted to investors in private placement     154,990     $ 0.50   2/11/2013
Granted to investors in private placement     197,663     $ 1.44   3/24/2013
Granted to debtor as a Commitment warrant     4,000,000     $ 2.00   8/31/2017
Granted to debtor as a Draw warrant     1,000,000     $ 2.13   9/20/2017
Granted to debtor as a Draw warrant     500,000     $ 2.27   10/17/2017
Granted to debtor as a Draw warrant     1,500,000     $ 2.11   11/6/2017
Total outstanding warrants accounted for as derivative warrant liability     7,360,153            
Weighted average exercise price           $ 2.01    
Weighted average time to expiration in years                 4.50 years

 

Outstanding warrants accounted for in equity:

                 
Granted to investors in private placement of preferred stock     32,249     $ 1.00   9/30/2013
Granted to investors in private placement of preferred stock     198,333     $ 1.50   10/28/2013
Granted to investors in private placement of preferred stock     390,000     $ 0.75   2/28/2014
Granted to vendor     60,000     $ 0.60   3/15/2014
Granted to investors in private placement     400,000     $ 1.59   6/30/2014
Granted to investors in private placement     768,000     $ 2.00   11/13/2014
Granted to placement agent in private placement     256,906     $ 1.50   11/13/2014
Granted to investors in private placement     63,000     $ 2.00   12/3/2014
Granted to investors in private placement     341,325     $ 2.25   2/9/2015
Granted to placement agents in private placement     28,500     $ 2.25   2/9/2015
Granted to investor in private placement     6,375     $ 2.25   3/18/2015
Granted to financial investment advisor     100,000     $ 1.50   2/10/2013
Granted to financial investment advisor     10,367     $ 2.00   3/3/2013
Granted to investors in private placement     245,750     $ 1.50   1/4/2013
Granted to investors in private placement     245,750     $ 2.50   1/4/2013
Granted to placement agent in private placement     18,125     $ 1.50   1/4/2013
Granted to placement agent in private placement     18,125     $ 2.50   1/4/2013
Granted to investors in private placement     255,000     $ 1.50   2/3/2013
Granted to investors in private placement     280,000     $ 2.50   2/3/2013
Granted to placement agent in private placement     1,250     $ 1.50   2/3/2013
Granted to placement agent in private placement     1,250     $ 2.50   2/3/2013
Granted to investors in private placement     250,000     $ 1.50   2/8/2013
Granted to investors in private placement     250,000     $ 2.50   2/8/2013
Granted to investors in private placement     959,582     $ 3.00   12/7/2014
Total outstanding warrants accounted for as equity     5,179,887            
Weighted average exercise price           $ 2.00    
Weighted average time to expiration in years                 1.18 years

 

Totals for all warrants outstanding:

                 
Total     12,540,040            
Weighted average exercise price           $ 2.01    
Weighted average time to expiration in years                 3.13 years

us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock